Table 1

Demographic and baseline clinical characteristics for the 379 patients.

Mean (SD)

Number (%)


Age at inclusion, years

57 (15)

Disease duration, months

6.3 (3.2)

Women

241 (64)

Anti CCP positive

210 (61)

RF positive

221 (65)

DAS28

5.07 (1.2)

ESR

38 (26)

CRP, mg/L

37 (38)

HAQ, 0-3

0.97 (0.61)

Total Sharp score (SHS)

4.0 (8.2)

Erosion score (ES)

1.7 (3.8)

Joint space narrowing score (JSN)

2.3 (5.2)

Prednisolone

1876 (50)

DMARDS

None

77 (20)

Methotrexate

155 (41)

Sulfasalazine

102 (27)

Other DMARD

44 (12)

Combination

1 (0)

Biologics

0 (0)


Anti-CCP, antibodies against cyclic citrullinated peptides; CRP, C-reactive protein; DAS28, Disease Activity Score calculated on 28 joints; DMARDS, disease modifying anti-rheumatic drugs; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; N, number; RF, rheumatoid factor; SD, standard deviation.

Forslind et al. Arthritis Research & Therapy 2012 14:R219   doi:10.1186/ar4058

Open Data